Earnings History Data for Indivior PLC (INDV) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Indivior PLC

Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
25-04-2024	PM	INDV	Indivior PLC	2,530	0.37	0.38	0.40		17.29	-1.52 (-8.08%)	17.93	-0.88 (-4.68%)	14.38 - 26.50	312,772	100,000	5,166

22-02-2024	PM	INDV	Indivior PLC	2,420	0.43	0.28	0.27	Indivior non-GAAP EPS of $0.43, revenue of $293M [2/22/2024 9:06 AM]	21.33	3.83 (21.89%)	20.08	2.58 (14.74%)	14.38 - 26.50	400,119	120,000	17,905
Indivior weighs moving primary listing to U.S. [2/22/2024 7:34 AM] Indivior non-GAAP EPS of $0.43, revenue of $293M [2/22/2024 9:06 AM]